Bath & Body Works (BBWI) Down 9.9% Since Last Earnings Report: Can It Rebound?
Bath & Body Works (BBWI) reported earnings 30 days ago. What's next for the stock?
BBWI - Bath & Body Works, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$21.17
DETAILS
HIGH:
$24.00
LOW:
$19.00
MEDIAN:
$21.00
CONSENSUS:
$21.17
UPSIDE:
28.69%
Stock News
New Strong Sell Stocks for September 16th
AGCO, BSX and BBWI have been added to the Zacks Rank #5 (Strong Sell) List on September 16th, 2026.
Bath & Body Works Inc (BBWI) Stock Down 6.3% -- Now Undervalued? GF Score: 66/100
On September 09, 2026, Bath and Body Works Inc (BBWI) shares fell 6.3% to a current price of $17.71, continuing a broader downward trend that has seen the stock d
Public Employees Retirement System of Ohio Makes New Investment in Bath & Body Works, Inc. $BBWI
Public Employees Retirement System of Ohio bought a new stake in shares of Bath and Body Works, Inc. (NYSE: BBWI) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 57,298 shares of the company's stock, valued at approximately $1,325,000. A
Jupiter Topco LLC Makes New Investment in Bath & Body Works, Inc. $BBWI
Jupiter Topco LLC acquired a new stake in shares of Bath and Body Works, Inc. (NYSE: BBWI) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 79,100 shares of the company's stock, valued at approximately $1,830,000. Several other large investors
BBWI Stock Jumps 7.5% on Q2 Earnings Beat, Fiscal 2026 Outlook Raised
Bath & Body Works stock surges 7.5% after a Q2 earnings beat, stronger direct sales and a higher FY'26 outlook signal improving momentum.
These Analysts Slash Their Forecasts On Bath & Body Works Following Q2 Results
Bath & Body Works, Inc. (NYSE:BBWI) on Wednesday reported better-than-expected second-quarter financial results and raised its FY26 EPS guidance.
Bath & Body Works: Market Expectations Are Set Too Low
Bath & Body Works, Inc. reported volatile Q2 earnings. Weak store sales continue to pressure the company's earnings power. There were positive signals in BBWI's results as well. Ecommerce sales improved, international & wholesale revenues grew very well, and the FY2026 guidance was raised slightly. Market expectations have been set at an overly pessimistic level. I estimate BBWI stock to have 54% upside to $29.10.
Traders Buy Large Volume of Put Options on Bath & Body Works (NYSE:BBWI)
Bath and Body Works, Inc. (NYSE: BBWI - Get Free Report) was the target of unusually large options trading on Tuesday. Stock investors bought 23,399 put options on the stock. This represents an increase of approximately 550% compared to the average daily volume of 3,601 put options. Wall Street Analysts Forecast Growth BBWI has been the
Here's What Key Metrics Tell Us About Bath & Body Works (BBWI) Q2 Earnings
Although the revenue and EPS for Bath & Body Works (BBWI) give a sense of how its business performed in the quarter ended July 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Bath & Body Works: The Market Is Ignoring This Turnaround Story - For Now
Bath & Body Works, Inc. remains a Strong Buy, with valuation deeply discounted despite improving fundamentals and robust cash flow. Q2 saw adjusted EPS up 67.6% and guidance raised, with management targeting $650 million in free cash flow and $250 million in cost savings. BBWI's balance sheet is strengthening through debt repayments and cash generation, positioning it for future buybacks and further expansion.
Bath & Body Works, Inc. (BBWI) Q2 2027 Earnings Call Transcript
Bath & Body Works, Inc. (BBWI) Q2 2027 Earnings Call Transcript
Retail's Big Q2 Beats Came From Washington, Not the Consumer
Any Q2 retail EPS comparison that ignores tariff refunds is measuring the refund, not the business.
Bath & Body Works Q2 Earnings Call Highlights
Bath & Body Works NYSE: BBWI reported second-quarter results that exceeded its prior outlook, though sales remained under pressure as the retailer invests in product innovation, marketing, digital capabilities and expanded distribution to support a planned return to revenue growth in 2027.
Bath & Body Works results top expectations, lower third quarter earnings expected
Bath & Body Works Inc (NYSE:BBWI) on Wednesday reported second quarter fiscal 2026 results above expectations, while the company also raised its full-year adjusted earnings outlook. The retailer reported net sales of $1.51 billion for the quarter ended August 1, down 2.3% from $1.55 billion a year earlier and slightly above analyst expectations of approximately $1.50 billion.
Bath & Body Works (BBWI) Q2 Earnings and Revenues Surpass Estimates
Bath & Body Works (BBWI) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.37 per share a year ago.
Bath & Body Works Raises Earnings Outlook on Higher Profit
The soaps and fragrances retailer said it now expects annual adjusted earnings per share to be $2.60 to $2.80, up from prior guidance of $2.40 and $2.65.
Bath & Body Works lifts annual profit forecast as digital demand offsets weak store traffic
Bath & Body Works on Wednesday raised its forecast for full-year profit and beat estimates for second-quarter results, benefiting from demand for body care products and home fragrances on digital channels.
Bath & Body Works Reports Second Quarter Results Exceeding Guidance and Continued Progress on Transformation
Delivers Q2 net sales and adjusted earnings per share results above guidance Second quarter net sales of $1.5 billion, down 2.3%. Earnings per diluted share of $0.58; Adjusted earnings per diluted share of $0.62 Delivered growth in Direct net sales, supported by ongoing enhancements to the digital experience over the past year Raises full-year 2026 earnings per diluted share guidance to $3.13 to $3.33; adjusted earnings per diluted share guidance to $2.60 to $2.80 and narrows net sales guidance to a decline between 4% to 2.5% COLUMBUS, Ohio, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) today reported second quarter 2026 results.
Bath & Body Works Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Bath & Body Works, Inc. (NYSE:BBWI) will release its second earnings report before the opening bell on Wednesday, Aug. 26.
Price Targets
Bath & Body Works initiated with a Market Perform at BMO Capital
$20.00
(was $18.90)
BMO Capital
BMO Capital Starts Bath & Body Works Inc. (BBWI) at Market Perform
$20.00
(was $18.90)
China Renaissance Securities (US) Inc.
Bath & Body Works price target lowered to $22 from $23 at Deutsche Bank
$22.00
(was $18.07)
Deutsche Bank
Bath & Body Works price target lowered to $20 from $22 at Morgan Stanley
$20.00
(was $18.90)
Morgan Stanley
Bath & Body Works price target lowered to $23 from $25 at Baird
$23.00
(was $18.90)
Robert W. Baird
Bath & Body Works price target lowered to $24 from $26 at Wells Fargo
$24.00
(was $18.90)
Wells Fargo
Bath & Body Works price target lowered to $22 from $23 at Barclays
$22.00
(was $18.90)
Barclays
Bath & Body Works price target raised to $23 from $22 at Jefferies
$23.00
(was $20.49)
Jefferies
Bath & Body Works downgraded to Sell from Neutral at Goldman Sachs
$19.00
(was $20.62)
Kate McShane
·
Goldman Sachs
Bath & Body Works resumed with an Equal Weight at Morgan Stanley
$22.00
(was $21.27)
Morgan Stanley
Bath & Body Works price target raised to $26 from $25 at Wells Fargo
$26.00
(was $19.63)
Wells Fargo
Bath & Body Works price target lowered to $22 from $25 at Telsey Advisory
$22.00
(was $19.97)
Dana Telsey
·
Telsey Advisory
Bath & Body Works price target lowered to $23 from $26 at Goldman Sachs
$23.00
(was $19.45)
Goldman Sachs
Bath & Body Works price target lowered to $23 from $25 at Barclays
$23.00
(was $19.45)
Adrienne Yih
·
Barclays
Bath & Body Works price target lowered to $19 from $22 at UBS
$19.00
(was $16.60)
UBS
Bath & Body Works assumed with a Neutral at Piper Sandler
$20.00
(was $17.95)
Piper Sandler
Bath & Body Works price target raised to $22 from $21 at UBS
$22.00
(was $22.55)
UBS
Bath & Body Works assumed with a Hold at Jefferies
$24.00
(was $22.98)
Jefferies
Bath & Body Works resumed with a Hold at Deutsche Bank
$21.00
(was $22.53)
Deutsche Bank
Bath & Body Works price target raised to $21 from $17 at UBS
$21.00
(was $21.95)
Jay Sole
·
UBS